When to Take Silodal-D 8
Silodal-D 8 (silodosin 8 mg + dutasteride 0.5 mg) should be taken once daily with a meal. 1
Timing and Administration
- Take the medication with food – the FDA label explicitly states the recommended dose is 8 mg orally once daily with a meal 1
- Consistent daily timing optimizes therapeutic benefit, though the specific time of day (morning vs. evening) is not specified in the prescribing information 1
- Do not take on an empty stomach – food intake is required for proper absorption and to minimize gastrointestinal side effects 1
Special Instructions for Swallowing Difficulties
- If you cannot swallow the capsule whole, you may carefully open it and sprinkle the powder on one tablespoon of applesauce 1
- Swallow the applesauce mixture immediately (within 5 minutes) without chewing, followed by an 8 oz glass of cool water 1
- The applesauce must be cool (not hot) and soft enough to swallow without chewing 1
- Do not store the powder/applesauce mixture for later use – it must be consumed immediately 1
- Do not subdivide the capsule contents 1
Dosage Adjustments Based on Kidney Function
- Moderate renal impairment (creatinine clearance 30-50 mL/min): reduce dose to 4 mg once daily with a meal 1
- Severe renal impairment (creatinine clearance <30 mL/min): this medication is contraindicated 1
- Mild renal impairment (creatinine clearance 50-80 mL/min): no dose adjustment needed 1
Critical Safety Considerations
- Orthostatic hypotension risk: be cautious when standing up quickly, especially when first starting therapy – avoid driving or operating machinery until you know how the medication affects you 1
- Inform your ophthalmologist if you are planning cataract surgery, as silodosin (like other alpha-blockers) increases the risk of intraoperative floppy iris syndrome 2, 3
- Sexual side effects: combination therapy with dutasteride and silodosin increases adverse event rates typical of each drug class, including ejaculatory dysfunction 2, 3
- PSA monitoring: dutasteride lowers PSA values by approximately 50% after 6 months of therapy, so your doctor should double your PSA values when screening for prostate cancer 3
Expected Timeline for Benefit
- Alpha-blocker component (silodosin): symptom improvement typically begins within 4 weeks 3
- 5-ARI component (dutasteride): requires 3-6 months to demonstrate full clinical benefit for prostate size reduction and disease progression prevention 3
- Follow-up should be scheduled at 3-6 months rather than the usual 4-week reassessment used for alpha-blocker monotherapy alone 3